Gene expression-based prognostic signatures in lung cancer: ready for clinical use?
暂无分享,去创建一个
[1] Avrum Spira,et al. Guidelines: Expression profiling — best practices for data generation and interpretation in clinical trials , 2004 .
[2] David M Jablons,et al. Genomic prognostic models in early-stage lung cancer. , 2009, Clinical lung cancer.
[3] T. Lumley,et al. Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.
[4] Jeremy J. W. Chen,et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. , 2007, The New England journal of medicine.
[5] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] H. Dienemann,et al. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients. , 2007, Lung cancer.
[7] Douglas G Altman,et al. Reporting recommendations for tumor marker prognostic studies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Guidel Ines,et al. Expression profiling — best practices for data generation and interpretation in clinical trials , 2004, Nature Reviews Genetics.
[9] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[10] Zhifu Sun,et al. A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer , 2006, PLoS medicine.
[11] Rainer Spang,et al. Microarray Based Diagnosis Profits from Better Documentation of Gene Expression Signatures , 2008, PLoS Comput. Biol..
[12] P. Ravdin,et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Marcin Skrzypski,et al. A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma , 2008, Clinical Cancer Research.
[14] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[15] Masahiro Tsuboi,et al. The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer. , 2007, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[16] N. Hayward,et al. Expression profiling defines a recurrence signature in lung squamous cell carcinoma. , 2006, Carcinogenesis.
[17] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[18] L. V. van't Veer,et al. Clinical application of the 70-gene profile: the MINDACT trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] M. Tyers,et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. , 2002, Cancer research.
[20] Igor Jurisica,et al. Prognostic gene signatures for non-small-cell lung cancer , 2009, Proceedings of the National Academy of Sciences.
[21] Xianglin Shi,et al. Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma , 2006, Clinical Cancer Research.
[22] John M Drake,et al. Limits to Forecasting Precision for Outbreaks of Directly Transmitted Diseases , 2005, PLoS medicine.
[23] Marcin Skrzypski,et al. An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer , 2009, Clinical Cancer Research.
[24] Chaya S Moskowitz,et al. Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome. , 2004, Statistics in medicine.
[25] M. Pepe,et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. , 2004, American journal of epidemiology.
[26] Michael W Kattan,et al. Evaluating a New Marker’s Predictive Contribution , 2004, Clinical Cancer Research.
[27] A. Dupuy,et al. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. , 2007, Journal of the National Cancer Institute.
[28] M. Radmacher,et al. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. , 2003, Journal of the National Cancer Institute.
[29] Zhifu Sun,et al. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] S. Mukherjee,et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. , 2006, The New England journal of medicine.
[32] L. Tanoue,et al. Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer , 2009 .
[33] Shuta Tomida,et al. Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients , 2004, Oncogene.
[34] Igor Jurisica,et al. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.
[35] S. Paik,et al. Development of the 21-gene assay and its application in clinical practice and clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Yi Zhang,et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. , 2006, Cancer research.
[37] L. Tanoue. Staging of non-small cell lung cancer. , 2008, Seminars in respiratory and critical care medicine.
[38] N. Hayward,et al. Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma , 2007, Clinical Cancer Research.
[39] Marcin Skrzypski,et al. Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung , 2008, Clinical Cancer Research.
[40] Peter Dayan,et al. Serotonin, Inhibition, and Negative Mood , 2007, PLoS Comput. Biol..